News
RMD
275.96
+1.59%
4.33
ResMed (RMD) Is Up 5.2% After Strong Quarter, Dividend Hike And Completed Buyback Program
Simply Wall St · 1d ago
The Week That Was, The Week Ahead: Macro and Markets, Feb. 8
TipRanks · 1d ago
Why You Might Be Interested In ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend
Simply Wall St · 2d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of February 8
Seeking Alpha · 3d ago
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)
TipRanks · 3d ago
ResMed Builds Digital Sleep Apnea Ecosystem As Investors Track Valuation
Simply Wall St · 4d ago
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
Barchart · 5d ago
Top 50 High-Quality Dividend Growth Stocks For February 2026
Seeking Alpha · 5d ago
RMD Makes Bullish Cross Above Critical Moving Average
NASDAQ · 5d ago
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from UBS
TipRanks · 5d ago
ResMed At Wearable And AI Turning Point In Sleep Apnea Care
Simply Wall St · 6d ago
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions
NASDAQ · 6d ago
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds
NASDAQ · 6d ago
4 Medical Product Stocks to Watch From a Challenging Industry (Revised)
NASDAQ · 6d ago
Morgan Stanley Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 02/03 05:06
Assessing ResMed (RMD) Valuation After Strong Fiscal Q2 Earnings Beat And AI Product Momentum
Simply Wall St · 02/02 20:17
ResMed Is Maintained at Buy by Citigroup
Dow Jones · 02/02 19:44
ResMed Price Target Raised to $345.00/Share From $330.00 by Citigroup
Dow Jones · 02/02 19:44
Goldman Sachs Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 02/02 18:05
4 Medical Product Stocks to Watch From a Challenging Industry
NASDAQ · 02/02 14:08
More
Webull provides a variety of real-time RMD stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.